Back to Search
Start Over
Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B.
- Source :
-
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2007 Jan 15; Vol. 44 (2), pp. 311-2. - Publication Year :
- 2007
- Subjects :
- Aged
Amphotericin B adverse effects
Antiprotozoal Agents adverse effects
Drug Combinations
Female
Humans
Male
Middle Aged
Phosphatidylcholines adverse effects
Phosphatidylglycerols adverse effects
Pilot Projects
Amphotericin B therapeutic use
Antiprotozoal Agents therapeutic use
Leishmaniasis, Cutaneous drug therapy
Phosphatidylcholines therapeutic use
Phosphatidylglycerols therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1537-6591
- Volume :
- 44
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publication Type :
- Report
- Accession number :
- 17173238
- Full Text :
- https://doi.org/10.1086/510494